Table 1.
Adenosine receptor antagonist | ||||
---|---|---|---|---|
Non-selective | A1 | A2A | ||
CONCURRENT FR5/FREE CHOW | ||||
D2 receptor antagonist | Reversal | No reversal | Reversal | Farrar et al. (2007), Salamone et al. (2009), Worden et al. (2009) |
D1 receptor antagonist | – | No reversal | Partial reversal1 | Worden et al. (2009)1, Nunes et al. (2009)2 |
T-MAZE WITH BARRIER | ||||
D2 receptor antagonist | Reversal | No reversal | Reversal | Mott et al. (2009), Pardo (2009)3 |
1There was a mild increase in lever pressing in ecopipam-treated rats that received the A2A antagonist MSX-3, but no reversal of the chow intake effect of the D1 antagonist.
2Data from Nunes et al. (2009).
3Data from Pardo (2009), unpublished masters thesis, University of Jaume I.